BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19361404)

  • 1. [Histological types and prognostic factors in colorectal cancer].
    Selves J
    Med Sci (Paris); 2009 Mar; 25 Spec No 1():9-12. PubMed ID: 19361404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal carcinoma associated with serrated adenoma--prevalence, histological features, and prognosis.
    Mäkinen MJ; George SM; Jernvall P; Mäkelä J; Vihko P; Karttunen TJ
    J Pathol; 2001 Mar; 193(3):286-94. PubMed ID: 11241406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of molecular-pathologic entities of colorectal cancer].
    Kirchner T; Reu S
    Pathologe; 2008 Nov; 29 Suppl 2():264-9. PubMed ID: 18841367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and predictive factors in colorectal cancer.
    Zlobec I; Lugli A
    J Clin Pathol; 2008 May; 61(5):561-9. PubMed ID: 18326017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New prognostic parameters and categories of colorectal carcinoma--correlation with standards].
    Micev M; Cosić-Micev M; Krivokapić Z; Marković V; Popović M
    Acta Chir Iugosl; 1998; 45(2 Suppl):61-8. PubMed ID: 10951790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency.
    Jensen LH; Lindebjerg J; Byriel L; Kolvraa S; Crüger DG
    Colorectal Dis; 2008 Jun; 10(5):490-7. PubMed ID: 17868408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic parameters and DNA analysis in colorectal adenocarcinomas.
    Crissman JD; Zarbo RJ; Ma CK; Visscher DW
    Pathol Annu; 1989; 24 Pt 2():103-47. PubMed ID: 2671879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a new classification system for curatively resected colorectal adenocarcinoma.
    Sternberg A; Sibirsky O; Cohen D; Blumenson LE; Petrelli NJ
    Cancer; 1999 Sep; 86(5):782-92. PubMed ID: 10463976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and predictive factors in colorectal cancer.
    Zlobec I; Lugli A
    Postgrad Med J; 2008 Aug; 84(994):403-11. PubMed ID: 18832400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colorectal serrated adenoma: diagnostic criteria and clinical implications].
    Rüschoff J; Aust D; Hartmann A
    Verh Dtsch Ges Pathol; 2007; 91():119-25. PubMed ID: 18314605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of prognostic parameters in colorectal carcinoma. I. Histopathological variability].
    Lanza G; Borghi L; Ballotta MR; Ferretti S; Morsiani E; Buccoliero F; Navarra G; Piva E; Facchini L; Cavazzini L
    Pathologica; 1992; 84(1090):131-53. PubMed ID: 1331943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite instability is infrequent in medullary breast cancer.
    Lee SC; Berg KD; Sherman ME; Griffin CA; Eshleman JR
    Am J Clin Pathol; 2001 Jun; 115(6):823-7. PubMed ID: 11392877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular pathology of colorectal cancer].
    Bosman FT; Joris F
    Rev Med Suisse Romande; 1999 Oct; 119(10):775-82. PubMed ID: 10582488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
    Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
    Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma.
    García-Solano J; Pérez-Guillermo M; Conesa-Zamora P; Acosta-Ortega J; Trujillo-Santos J; Cerezuela-Fuentes P; Mäkinen MJ
    Hum Pathol; 2010 Oct; 41(10):1359-68. PubMed ID: 20594582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma.
    Yantiss RK; Goodarzi M; Zhou XK; Rennert H; Pirog EC; Banner BF; Chen YT
    Am J Surg Pathol; 2009 Apr; 33(4):572-82. PubMed ID: 19047896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
    Malesci A; Laghi L; Bianchi P; Delconte G; Randolph A; Torri V; Carnaghi C; Doci R; Rosati R; Montorsi M; Roncalli M; Gennari L; Santoro A
    Clin Cancer Res; 2007 Jul; 13(13):3831-9. PubMed ID: 17606714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatch repair protein MSH2, cytokeratin 18 and cytokeratin 20 expression: clinicopathological correlation and prognostic value in colorectal cancer patients.
    González JJ; Bernardo CG; Sanz L; Fresno MF; Barbón E; Noval JG; Martínez E
    Hepatogastroenterology; 2007 Dec; 54(80):2266-71. PubMed ID: 18265645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
    Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
    Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.